The FDA Enrichment In Silico Clinical Trial Project

A collaboration between Dassault Systèmes and the U.S. FDA on a groundbreaking application of virtual twins and generative AI in healthcare.

Virtual twin experiences open up new possibilities for Life Sciences and Healthcare - enabling us to invent new ways of representing life, by understanding and representing the invisible. This catalyzes core shifts in business processes, strategic planning and regulatory frameworks, as well as technological solutions.  From its DNA to its organs, the human body holds complex mysteries yet to be uncovered by science. Inefficiencies in today’s world of research and medicine, compounded with the need for more precise, sustainable patient care, have made the Life Sciences and Healthcare industry ripe for transformation. Shifting the focus to deliver superior, patient-centric, outcome-driven experiences and creating the processes to support them transforms how therapies are discovered, developed, produced, commercialized and used.

Virtual Twin Experiences In Healthcare: Next Generation Precision Medicine

Virtual Twin of Human - Virtual human twins and dedicated teams enable faster, safer treatments for longer, healthier lives

Serving the Needs of All Stakeholders Across the Life Sciences & Healthcare Value Chain

Pharmaceutical and Biotech
From concept to design and development, clinical trials, governance, manufacturing and after sales services, our solutions enable you to address your challenges and improve your competitiveness
MedTech
Transforming medical devices with sustainable innovation.
Patient Care
The patient care arena is changing rapidly with a laser focus on improving patient outcomes and a shift from episodic care to a continuous engagement in the Life Sciences Industry, embracing the consumerization of health with Dassault Systèmes solutions.

Addressing the Business Challenges of the Life Sciences & Healthcare Industry

The transformation required by Life Sciences companies includes core shifts in business processes, strategic planning, regulatory frameworks, as well as technological solutions. They are shifting their focus to deliver superior, patient-centric, outcome-driven experiences and create the processes to support them.

Multifactorial Complex Diseases
The rise of chronic diseases and number of patients with unmet medical needs as a result of an ageing population, lifestyle changes & urbanization has catalyzed the Life Sciences industry into action.
Access to Science & Technology Breakthroughs
By leveraging the scientific and technology breakthroughs available to them, Life Sciences companies can propel themselves ahead of the competition.
Patient Autonomy
Informed and demanding patients are now partners in their own healthcare putting pressure on the industry to deliver.
Better Access to Care for All, Everywhere
In reaction to the healthcare reform mandate, successful Life Sciences companies are reducing costs, demonstrating value and leveraging technology solutions, to improve access to care for everybody, everywhere
Intense Competition, New Players
Coupled with fierce competition in therapeutic areas of greatest return, the entry of non-traditional technology players puts added pressure on Life Sciences companies.
Data & Digitalization Imperative
Digital disruption has reached Life Sciences & Healthcare, and with it comes an imperative for Life Sciences companies to transform their core technology and leverage data and analytics to gain a competitive advantage.
Regulatory Pressure
For Life Sciences companies the regulatory landscape is constantly changing & with every change comes the increased risk of non-compliance.
The Sustainability Mandate
By leveraging the power of virtual universes to achieve their ESG goals, Life Sciences & Healthcare companies can propel the industry towards affordable, sustainable healthcare, for all.

Trends in the Life Sciences & Healthcare Industry